Alan Nurden: One of The Best Articles That I Have Read in 2025
Alan Nurden, Emeritus Research Director at CNRS, shared on LinkedIn:
”One of the best articles that I have read in 2025.
The wide-ranging pathophysiology of RUNX1 mutations is clearly illustrated through a series of case reports where families were gentotyped using a NGS-based sequencing panel.
The association of platelet function defects, thrombocytopenia and malignancy risk is highlighted case by case in a thoroughly professional manner.
Highly recommended.”
Read the full article in Frontiers.
Article: RUNX1-FPDMM in families with mild thrombocytopenia and platelet function anomalies: a case series
Authors: Hannah Glonnegger, Doris Boeckelmann, Rebekka Wiedenhöfer, Wolf-Achim Hassenpflug, Tim Ripperger, Dirk Lebrecht, Ralf Knöfler, Oliver Tiebel, Udo Koehler, Claudia Wehr, Harry Sirb, Monika Sparber-Sauer, Katrin Reinsberger, Ayami Yoshimi, Brigitte Strahm, Barbara Zieger
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 9, 2026, 12:41Thomas Palmer-Dench: Hexokinase Controls Platelet Activation and Hemostasis
-
Jul 9, 2026, 12:19Paschalis Evangelidis: Join Our Special Issue on Thrombosis and Vascular Disorders
-
Jul 9, 2026, 12:16Fernanda Betti Solano: Could Iron Deficiency Be Affecting Your Sleep?
-
Jul 9, 2026, 12:08Andreas Calatzis: What is the Rationale for Collagen-Induced Platelet Aggregation Testing?
-
Jul 9, 2026, 11:54Deepak Pradhan։ Can Withaferin-A Help Combat Drug-Resistant Malaria?
-
Jul 9, 2026, 11:26Peter Zhang: Is Canada Ready for the Gene Therapy Era?
-
Jul 9, 2026, 09:35Pradeebha Muthukumar: Do You Know the Signs of Anemia?
-
Jul 9, 2026, 09:24Maryam Majid: Machine Learning for Anemia Risk Prediction
-
Jul 9, 2026, 08:46Jordan Agay: Folate Deficiency in Patients Receiving PARP Inhibitors